Dr. Andreas Raabe

Dr. Andreas Raabe serves as the Chief Executive Officer of Adragos Pharma since July 2020, leading a globally operating Contract Development and Manufacturing Organisation with operations across multiple countries. Additionally, Dr. Raabe holds positions as a Board Member at BioAnalyt, empowering food safety and quality initiatives, and Chairman of the Board at YPO, a global leadership community. Previously, Dr. Raabe has served as CEO of VERTANICAL GmbH, Vice President at Aenova Group, and Director of Global Strategy at Sandoz, among other roles. Academic qualifications include a Ph.D. in Biology from Imperial College London and a Doctor of Philosophy in Biological and Biomedical Sciences from EMBL.